No results...

The European Commission publishes the evaluation of the Second European and Developing Countries Clinical Trials Partnership

9 May 2023

News
The European Commission publishes the evaluation of the Second European and Developing Countries Clinical Trials Partnership

The European Commission publishes the evaluation of the Second European and Developing Countries Clinical Trials Partnership

The European and Developing Countries Clinical Trials Partnership Programme (EDCTP) was launched in 2003 in response to the global health crisis caused by HIV/AIDS, malaria and tuberculosis. The programme aims to accelerate the clinical development of new or improved health technologies for the identification, treatment, and prevention of poverty-related and neglected infectious diseases. To this end, the EDCTP funds activities for research capacity building in Africa, supporting researchers’ careers and strengthening national health research systems. In 2014, the programme was renewed as EDCTP2, with funding through to 2024.

PPMI was contracted by the European Commission to carry out the second interim evaluation of EDCTP2, with a specific focus on its performance between 2017 and 2021. The European Commission has recently published evaluation. Findings suggest that EDCTP2 remained highly relevant both within the EU but also globally, largely coherent with other parts of Horizon 2020 and relevant initiatives as well as efficient and effective in terms of achieving the intended results. Finally, the report concludes that the added value of EDCTP2 was multi-fold in the area of poverty-related diseases in sub-Saharan Africa. While the programme implements collaborative clinical research projects on a scale, scope and time frame which would not be possible otherwise, it also broadens research collaboration between European and African countries and triggers new capacity building activities.

The evaluation results will inform the European Commission's final evaluation of the European Framework Programme for Research and Innovation – Horizon 2020. In addition, they will also serve as a strong basis for the subsequent evaluation of the Global Health EDCTP3 Joint Undertaking, which has been launched by the EC under Horizon Europe to preserve and further advance the long-term impact of the programme.

Photo credit: edctp.org.